Stockscreener 앱 받기
32.52
2.08%
-0.725
전일 마감가:
$33.24
열려 있는:
$32.97
하루 거래량:
222.43K
Relative Volume:
0.47
시가총액:
$1.43B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+1.40%
1개월 성능:
+20.07%
6개월 성능:
+200.00%
1년 성능:
+0.00%
1일 변동 폭
$31.47
$33.70
1주일 범위
$31.17
$34.29
52주 변동 폭
$6.71
$34.29
Maze Therapeutics Inc Stock (MAZE) Company Profile
명칭
Maze Therapeutics Inc
전화
(650) 850-5070
주소
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
MAZE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MAZE
Maze Therapeutics Inc
|
32.51 | 1.60B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.71 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.74 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.50 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.64 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.63 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Maze Therapeutics Inc Stock (MAZE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-02 | 개시 | BTIG Research | Buy |
| 2025-07-23 | 개시 | H.C. Wainwright | Buy |
| 2025-07-08 | 개시 | Wedbush | Outperform |
Maze Therapeutics Inc 주식(MAZE)의 최신 뉴스
Heatmap analysis for Maze Therapeutics Inc. and competitorsMarket Risk Analysis & Real-Time Volume Trigger Notifications - newser.com
Maze Therapeutics to Participate in Four Upcoming Investor Conferences - The Manila Times
Maze Therapeutics (NASDAQ: MAZE) to participate in four conferences; webcasts for 60 days - Stock Titan
Can you recover from losses in Maze Therapeutics Inc.Market Growth Review & Safe Swing Trade Setups - newser.com
Is Maze Therapeutics Inc. stock attractive for long term wealth building2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com
Price action breakdown for Maze Therapeutics Inc.Quarterly Profit Report & AI Powered Market Entry Ideas - newser.com
Is Maze Therapeutics Inc. stock recession proof2025 Short Interest & Fast Gaining Stock Reports - newser.com
Will Maze Therapeutics Inc. stock deliver consistent dividendsEarnings Summary Report & AI Enhanced Trading Alerts - newser.com
Maze Therapeutics Inc. stock momentum explained2025 Trading Recap & Intraday High Probability Alerts - newser.com
What is the fair value of Maze Therapeutics Inc. stock now2025 Sector Review & Accurate Entry/Exit Alerts - newser.com
Can Maze Therapeutics Inc. stock beat market expectations this quarterWeekly Stock Summary & Expert Curated Trade Setup Alerts - newser.com
Is Maze Therapeutics Inc. stock oversold or undervaluedMarket Performance Recap & High Accuracy Swing Entry Alerts - newser.com
Regression analysis insights on Maze Therapeutics Inc. performanceMarket Trend Review & Reliable Entry Point Alerts - newser.com
Will Maze Therapeutics Inc. outperform the marketAnalyst Downgrade & Safe Entry Trade Signal Reports - newser.com
How institutional buying supports Maze Therapeutics Inc. stockIPO Watch & Free Fast Entry Momentum Trade Alerts - newser.com
Does Maze Therapeutics Inc. qualify in momentum factor screeningJuly 2025 Short Interest & AI Powered Market Entry Strategies - newser.com
Applying chart zones and confluence areas to Maze Therapeutics Inc.July 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Pattern recognition hints at Maze Therapeutics Inc. upsideTrade Volume Report & Real-Time Stock Price Movement Reports - newser.com
Analyzing Maze Therapeutics Inc. with multi timeframe chartsJuly 2025 Big Picture & Safe Entry Momentum Stock Tips - newser.com
Published on: 2025-11-01 11:35:52 - newser.com
Published on: 2025-11-01 02:20:20 - newser.com
Maze Therapeutics (NASDAQ:MAZE) Trading 9.6% HigherShould You Buy? - MarketBeat
Top chart patterns to watch in Maze Therapeutics Inc.Analyst Downgrade & Safe Capital Growth Plans - newser.com
Biotech Stocks Hit 52-Week Highs: MTSR, INSM, ABVX, MAZE Lead October 30 Surge - RTTNews
Published on: 2025-10-31 01:35:39 - newser.com
Why Maze Therapeutics Inc. is moving todayWeekly Loss Report & AI Based Buy/Sell Signal Reports - newser.com
Published on: 2025-10-30 05:09:48 - newser.com
Maze Therapeutics Inc (MAZE) 재무 분석
Maze Therapeutics Inc (MAZE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):